Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8714-8722

  Unzueta, Ugutz ^a,b   Ferrer Miralles, Neus ^a,b   Cedano, Juan ^c   Zikung, Xu ^a,b   Pesarrodona, Mireia ^a,b   Saccardo, Paolo ^a,b   García Fruitós, Elena ^a,b   Domingo Espín, Joan ^a,b   Kumar, Pradeep ^d   Gupta, Kailash C ^e   Mangues, Ramón ^b,f   Villaverde, Antonio ^a,b   Vazquez, Esther ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^d CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^e CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Artificial viruses; Cationic peptides; Electrostatic interactions; Nanoparticles; Peptide tags; Protein engineering

Indexed keywords

AMYLOIDOGENIC PEPTIDES; ARTIFICIAL VIRUS; BIO-INSPIRED; BIOFABRICATION; BUILDING BLOCKES; CATIONIC PEPTIDES; CELL BINDING; CONVENTIONAL DRUGS; CYTOSOLIC; DNA CONDENSATION; FUNCTIONALIZED MONOMERS; HIS-TAGGED PROTEINS; INTERACTIVITY; LIMITED SPECTRUM; MONODISPERSE; NANO SCALE; NANOMEDICINES; NUCLEAR TARGETING; PEPTIDE TAGS; PROTEIN ENGINEERING; SELF-ASSEMBLING; WIDE SPECTRUM;

ARGININE; COULOMB INTERACTIONS; ELECTROSTATICS; GENETIC ENGINEERING; NANOPARTICLES; NANOTECHNOLOGY; NUCLEIC ACIDS; VIRUSES;

PEPTIDES;

NANOPARTICLE; NONAMYLOIDOGENIC PEPTIDE TAG; PEPTIDE; POLYARGININE; POLYHISTIDINE; PROTEIN ONLY NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CYTOARCHITECTURE; MOLECULAR INTERACTION; NANOFABRICATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; STATIC ELECTRICITY;

HELA CELLS; HISTIDINE; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PEPTIDES; PROTEIN ENGINEERING; PROTEINS; STATIC ELECTRICITY;

EID: 84866169525     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.033     Document Type: Article

References (81)

1. Uchida M., Klem M.T., Allen M., Suci P., Flenniken M., Gillitzer E., et al. Biological containers: protein cages as multifunctional nanoplatforms. Adv Mater 2007, 19:1025-1042.
2. Kim H.H., Choi H.S., Yang J.M., Shin S. Characterization of gene delivery in vitro and in vivo by the arginine peptide system. Int J Pharm 2007, 335:70-78.
3. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001, 276:5836-5840.
4. Vazquez E., Ferrer-Miralles N., Mangues R., Corchero J.L., Schwartz S., Villaverde A. Modular protein engineering in emerging cancer therapies. Curr Pharm Des 2009, 15:893-916.
5. Vazquez E., Ferrer-Miralles N., Villaverde A. Peptide-assisted traffic engineering for nonviral gene therapy. Drug Discov Today 2008, 13:1067-1074.
6. Ferrer-Miralles N., Vazquez E., Villaverde A. Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol 2008, 26:267-275.
7. Toledo-Rubio V., Vazquez E., Platas G., Domingo-Espín J., Unzueta U., Steinkamp E., et al. Protein aggregation and soluble aggregate formation screened by a fast microdialysis assay. J Biomol Screen 2010, 15:453-457.
8. Mastrobattista E., van der Aa M.A., Hennink W.E., Crommelin D.J. Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov 2006, 5:115-121.
9. Edelstein M.L., Abedi M.R., Wixon J. Gene therapy clinical trials worldwide to 2007 - an update. J Gene Med 2007, 9:833-842.
10. Corchero J.L., Cedano J. Self-assembling, protein-based intracellular bacterial organelles: emerging vehicles for encapsulating, targeting and delivering therapeutical cargoes. Microb Cell Fact 2011, 10:92.
11. Aris A., Villaverde A. Modular protein engineering for non-viral gene therapy. Trends Biotechnol 2004, 22:371-377.
12. Saccardo P., Villaverde A., Gonzalez-Montalban N. Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol Adv 2009, 27:432-438.
13. Koutsopoulos S., Unsworth L.D., Nagai Y., Zhang S. Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc Natl Acad Sci U S A 2009, 106:4623-4628.
14. Zhang S., Holmes T., Lockshin C., Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A 1993, 90:3334-3338.
15. Wu W., Xing L., Zhou B., Lin Z. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact 2011, 10:9.
16. Zhou B., Xing L., Wu W., Zhang X.E., Lin Z. Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb Cell Fact 2012, 11:10.
17. Vazquez E., Roldan M., Diez-Gil C., Unzueta U., Domingo-Espín J., Cedano J., et al. Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide. Nanomedicine (Lond) 2010, 5:259-268.
18. Vazquez E., Cubarsi R., Unzueta U., Roldán M., Domingo-Espín J., Ferrer-Miralles N., et al. Internalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticles. Biomaterials 2010, 31:9333-9339.
19. Vazquez E., Corchero J.L., Villaverde A. Post-production protein stability: trouble beyond the cell factory. Microb Cell Fact 2011, 10:60.
20. Martinez-Alonso M., Gonzalez-Montalban N., Garcia-Fruitos E., Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 2009, 8:4.
21. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
23. Dolinsky T.J., Czodrowski P., Li H., Nielsen J.E., Jensen J.H., Klebe G., et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 2007, 35:W522-W525.
24. Cavallo L., Kleinjung J., Fraternali F. POPS: a fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Res 2003, 31:3364-3366.
25. Eswar N., Eramian D., Webb B., Shen M.Y., Sali A. Protein structure modeling with MODELLER. Methods Mol Biol 2008, 426:145-159.
26. Kelley L.A., Sternberg M.J. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009, 4:363-371.
27. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.
28. Willard L., Ranjan A., Zhang H., Monzavi H., Boyko R.F., Brian D., et al. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 2003, 31:3316-3319.
29. Dominguez C., Boelens R., Bonvin A.M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 2003, 125:1731-1737.
30. Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., et al. Scalable molecular dynamics with NAMD. J Comput Chem 2005, 26:1781-1802.
31. Hsin J., Arkhipov A., Yin Y., Stone J.E., Schulten K. Using VMD: an introductory tutorial. Curr Protoc Bioinformatics 2008, Chapter 5: Unit 5.7.
32. Aris A., Villaverde A. Molecular organization of protein-DNA complexes for cell-targeted DNA delivery. Biochem Biophys Res Commun 2000, 278:455-461.
33. Unzueta U., Cespedes M.V., Ferrer-Miralles N., Casanova I., Cedano J.A., Corchero J.L., et al. Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles. Int J Nanomed 2012, 7:4533-4544.
34. Ferrer-Miralles N., Corchero J.L., Kumar P., Cedano J.A., Gupta K.C., Villaverde A., et al. Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine. Microb Cell Fact 2011, 10:101.
35. Zhang L., Pornpattananangku D., Hu C.M., Huang C.M. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 2010, 17:585-594.
36. Sarker D.K. Sculpted amphiphilic liposomal particles for modifiable medicinal applications. Curr Drug Discov Technol 2009, 6:52-58.
37. Sarker D.K. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2005, 2:297-310.
38. Huynh N.T., Passirani C., Saulnier P., Benoit J.P. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009, 379:201-209.
39. Patel D., Sawant K.K. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv 2009, 6:419-424.
40. Maham A., Tang Z., Wu H., Wang J., Lin Y. Protein-based nanomedicine platforms for drug delivery. Small 2009, 5:1706-1721.
41. Mao C., Flynn C.E., Hayhurst A., Sweeney R., Qi J., Georgiou G., et al. Viral assembly of oriented quantum dot nanowires. Proc Natl Acad Sci U S A 2003, 100:6946-6951.
42. Mao C., Solis D.J., Reiss B.D., Kottmann S.T., Sweeney R.Y., Hayhurst A., et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 2004, 303:213-217.
43. Nam K.T., Kim D.W., Yoo P.J., Chiang C.Y., Meethong N., Hammond P.T., et al. Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes. Science 2006, 312:885-888.
44. Goldmann C., Stolte N., Nisslein T., Hunsmann G., Luke W., Petry H. Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. J Virol Methods 2000, 90:85-90.
45. Georgens C., Weyermann J., Zimmer A. Recombinant virus like particles as drug delivery system. Curr Pharm Biotechnol 2005, 6:49-55.
46. Xu Y.F., Zhang Y.Q., Xu X.M., Song G.X. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes. Arch Virol 2006, 151:2133-2148.
47. Malboeuf C.M., Simon D.A., Lee Y.E., Lankes H.A., Dewhurst S., Frelinger J.G., et al. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine 2007, 25:3270-3276.
48. Lee T.J., Schwartz C., Guo P. Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann Biomed Eng 2009, 37:2064-2081.
49. Hiratsuka Y., Miyata M., Tada T., Uyeda T.Q. A microrotary motor powered by bacteria. Proc Natl Acad Sci U S A 2006, 103:13618-13623.
50. Kumara M.T., Muralidharan S., Tripp B.C. Generation and characterization of inorganic and organic nanotubes on bioengineered flagella of mesophilic bacteria. J Nanosci Nanotechnol 2007, 7:2260-2272.
51. Deplanche K., Woods R.D., Mikheenko I.P., Sockett R.E., Macaskie L.E. Manufacture of stable palladium and gold nanoparticles on native and genetically engineered flagella scaffolds. Biotechnol Bioeng 2008, 101:873-880.
52. Aris A., Feliu J.X., Knight A., Coutelle C., Villaverde A. Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. Biotechnol Bioeng 2000, 68:689-696.
53. Hassane F.S., Ivanova G.D., Bolewska-Pedyczak E., Abes R., Arzumanov A.A., Gait M.J., et al. A peptide-based dendrimer that enhances the splice-redirecting activity of PNA conjugates in cells. Bioconjug Chem 2009, 20:1523-1530.
54. Rodriguez-Carmona E., Villaverde A. Nanostructured bacterial materials for innovative medicines. Trends Microbiol 2010, 18:423-430.
55. Villaverde A. Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact 2010, 9:53.
56. Straub J.E., Thirumalai D. Principles governing oligomer formation in amyloidogenic peptides. Curr Opin Struct Biol 2010, 20:187-195.
57. Reddy G., Straub J.E., Thirumalai D. Dynamics of locking of peptides onto growing amyloid fibrils. Proc Natl Acad Sci U S A 2009, 106:11948-11953.
58. Espargaro A., Villar-Pique A., Sabate R., Ventura S. Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb Cell Fact 2012, 11:89.
59. Villar-Pique A., Espargaro A., Sabate R., de Groot N.S., Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact 2012, 11:55.
60. Garcia-Fruitos E., Sabate R., de Groot N.S., Villaverde A., Ventura S. Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J 2011, 278:2419-2427.
61. Martinez-Alonso M., Gonzalez-Montalban N., Garcia-Fruitos E., Villaverde A. The functional quality of soluble recombinant polypeptides produced in Escherichia coli is defined by a wide conformational spectrum. Appl Environ Microbiol 2008, 101:1353-1358.
62. Schrodel A., de M.A. Characterization of the aggregates formed during recombinant protein expression in bacteria. BMC Biochem 2005, 6:10.
63. Collins L., Parker A.L., Gehman J.D., Eckley L., Perugini M.A., Separovic F., et al. Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol. ACS Nano 2010, 4:2856-2864.
64. Yang Y.L., Khoe U., Wang X.M., Horii A., Yokoi H., Zhang S.G. Designer self-assembling peptide nanomaterials. Nano Today 2009, 4:193-210.
65. Wright E.R., Conticello V.P. Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. Adv Drug Deliv Rev 2002, 54:1057-1073.
66. Futaki S., Nakase I., Tadokoro A., Takeuchi T., Jones A.T. Arginine-rich peptides and their internalization mechanisms. Biochem Soc Trans 2007, 35:784-787.
67. Melikov K., Chernomordik L.V. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell Mol Life Sci 2005, 622739-622749.
68. Satheshkumar P.S., Lokesh G.L., Murthy M.R., Savithri H.S. The role of arginine-rich motif and beta-annulus in the assembly and stability of Sesbania mosaic virus capsids. J Mol Biol 2005, 353:447-458.
69. Ejima D., Yumioka R., Arakawa T., Tsumoto K. Arginine as an effective additive in gel permeation chromatography. J Chromatogr A 2005, 1094:49-55.
70. Tsumoto K., Umetsu M., Kumagai I., Ejima D., Philo J.S., Arakawa T. Role of arginine in protein refolding, solubilization, and purification. Biotechnol Prog 2004, 20:1301-1308.
71. Ferrari M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol 2010, 28:181-188.
72. Jiang W., Kim B.Y., Rutka J.T., Chan W.C. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008, 3:145-150.
73. Murakami T., Zhang T.Y., Koyanagi Y., Tanaka Y., Kim J., Suzuki Y., et al. Inhibitory mechanism of the CXCR4 antagonist t22 against human immunodeficiency virus type 1 infection. Journal of Virology 1999, 73:7489-7496.
74. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., et al. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997, 186:139-146.
75. Kledal T.N., Rosenkilde M.M., Coulin F., Simmons G., Johnsen A.H., Alouani S., et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 1997, 277:1656-1659.
76. Zhou N.M., Luo Z.W., Luo J.S., Hall J.W., Huang Z.W. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Biochemistry 2000, 39:3782-3787.
77. Demeule M., Regina A., Che C., Poirier J., Nguyen T., Gabathuler R., et al. Identification and design of peptides as a new drug delivery system for the brain. Journal of Pharmacology and Experimental Therapeutics 2008, 324:1064-1072.
78. Maggie J., Hsiang-Fa L., Sing-Ming C., Yi-Ju K., Li-Wen C. Peptide for transmigration across brain blood barrier and delivery systems comprising the same. 12/979, 804 [US2011/0165079 A1] 2010, US.
79. Hibino S., Shibuya M., Engbring J.A., Mochizuki M., Nomizu M., Kleinman H.K. Identification of an active site on the laminin alpha 5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 2004, 64:4810-4816.
80. Jalkanen S., Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992, 116:817-825.
81. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 2001, 98:10037-10041.